Breast

Most recent

New Strategies in the Treatment of HER2-Positive Breast Cancer

NE Oncology Issue - February 2014 Breast cancer Overexpression of the human epidermal growth factor receptor 2 (HER2) protein is detected in the tumours of approximately 20% of patients with breast cancer, conferring an aggressive phenotype...

Confirmatory overall survival analysis of CLEOPATRA: a randomized, doubleblind, placebo-controlled phase III study with pertuzumab, trastuzumab, and docetaxel in patients with HER2-positive first-line metastatic breast cancer

NE Oncology Issue - April 2013 Swain S, et al. SABCS 2012:P5-18-26 Background The CLEOPATRA (Clinical Evaluation of Pertuzumab and Trastuzumab) study randomized patients with human epidermal growth factor receptor 2 (HER2)- positive first-line metastatic breast cancer...

Twitter feed

Already looking forward to #ASH19 ? The NE Live Team has you covered until then. Catch up on perspectives captured… https://t.co/TPVZDwe1nc
h J R
Unable to attend #ASH18 ? NE Live was on site to capture up-to-the-minute perspectives on pivitol research. Visit… https://t.co/hyGWk82vqo
h J R
Watch the NE Live team discuss The GRIFFIN Study in Patients with Newly Diagnosed Multiple Myeloma Eligible for HDT… https://t.co/bIY5TzmT9L
h J R
The NE Live team caught up with Dr. Laurie Sehn on day 2 of #ASH18 to discuss The AUGMENT Study with Lenalidomide a… https://t.co/vE7NnCBL40
h J R

Other

Twitter feed

Already looking forward to #ASH19 ? The NE Live Team has you covered until then. Catch up on perspectives captured… https://t.co/TPVZDwe1nc
h J R
Unable to attend #ASH18 ? NE Live was on site to capture up-to-the-minute perspectives on pivitol research. Visit… https://t.co/hyGWk82vqo
h J R
Watch the NE Live team discuss The GRIFFIN Study in Patients with Newly Diagnosed Multiple Myeloma Eligible for HDT… https://t.co/bIY5TzmT9L
h J R
The NE Live team caught up with Dr. Laurie Sehn on day 2 of #ASH18 to discuss The AUGMENT Study with Lenalidomide a… https://t.co/vE7NnCBL40
h J R